Pain, depression and anxiety: is there a light at the end of the tunnel?

Rok vydání: 2021
Předmět:
Zdroj: Medicine of Ukraine. :14-18
ISSN: 1997-9894
DOI: 10.37987/1997-9894.2021.3(249).238034
Popis: In the present paper a modern sights to problem of chronic psychogenic pain and its relation to depressive and anxiety disorders have been looked. Based on this point of view, the requirements to choice of optimal pharmacological tool within complex therapy of psychogenic pain, depression and anxiety have been analyzed. A main attention paid to mechanisms of action and peculiarities of clinical use of drugs: duloxetine (Revival) – antidepressant from SNRI group with unique mechanisms of action and clinico-pharmacological properties, which make possible to realize the on-time impact on the mechanisms of development of depression and psychogenic pain; and pregabaline (Ligato) – drug from the anticonvulsants group, which influenced on universal mechanisms of cell ionic permeability at anxiety disorders and psychogenic pain. A clinical efficacy of duloxetine (Revival) and pregabaline (Ligato), its safety characteristics, and recommendations of practical use have been looked in detail.
Databáze: OpenAIRE